The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: The intestinal type is associated with a better prognosis

Hepato-Gastroenterology

Volumn 54, Issue 78, 2007, Pages 1641-1644

  Roh, Young Hoon ^a   Kim, Young Hoon ^a,b   Lee, Hyoun Wook ^a   Kim, Su Jin ^a   Roh, Mee Sook ^a   Jeong, Jin Sook ^a   Jung, Ghap Joong ^a  

^a Dong A University   (South Korea)

^b Dong A University College of Medicine   (South Korea)

Author keywords

Ampulla of Vater carcinoma; Immunohistochemical staining

Indexed keywords

GLUCOSE TRANSPORTER 1; KERATIN; MUCIN 2;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME; VATER PAPILLA; VATER PAPILLA CARCINOMA;

ADENOCARCINOMA; AGED; AMPULLA OF VATER; CARCINOMA; COMMON BILE DUCT NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCINS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 35948972468     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Outerbridge, GW: Carcinoma of the papilla of Vater. Surgery 1913; 57:402-426.
2. Kimura W, Futakawa N, Yamagata S, et al: Different clinicopathologic findings in two different histologic types of carcinoma of the papilla of Vater. Jpn J Cancer Res 1994; 85:161-166.
3. Fischer HP, Zhou H: Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004; 11:301-309.
4. Matsubayashi H, Watanabe H, Yamaguchi T, et al: Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of Vater. Cancer 1999; 86:596-607.
5. Futakawa N, Kimura W, Wada Y, et al: Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater. Hepatogastroenterology 1996; 43:260-267.
6. Takashima M, Ueki T, Nagai E, et al: Carcinoma of the papilla of Vater associated with or without adenoma: a clinicopathologic analysis of 129 cases with Reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 2000; 13:1300-1307.
7. Kayahara M, Nagakawa T, Ohta T, et al: Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997; 121:611-617.
8. Klempnauer J, Ridder GJ, Pichlmayr R, et al: Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. Br J Surg 1995; 82:1686-1691.
9. Todoroki T, Koike N, Morishita Y, et al: Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003; 10:1136-1137.
10. Neoptolemos JP, Talbot IC, Shaw DC, at al: Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer 1988; 61:1403-1407.
11. Kimura W, Futakawa N, Zhao B: Neoplastic diseases of the papilla of Vater. J Hepatobiliary Pancreat Surg 2004; 11(4):223-231.
12. Kimura W, Ohtsubo K: Incidence, sites of origin, and immunohistochemical and histochemical characteristics of atypical epithelium and minute carcinoma of the papilla of Vater. Cancer 1988; 61:1394-1402.
13. Albores-Saavedra J, Henson DE, Klimstra DS: Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Rosai J, Sobin LH (Eds.). Atlas of tumor pathology, third series. Fascicle 27. Washington, DC: Armed Forces Institute of Pathology, 2000.
14. Yamaguchi K, Enjoji M: Carinoma of the ampulla of Vater. Cancer 1987; 59:506-515.
15. Komorowski RA, Beggs BK. Geenan JE, et al: Assessment of ampulla of Vater pathology. Am J Surg Pathol 1991; 15:1188-1196.
16. Younes M, Riley S, Genta RM, et al: p53 Protein accumulation in tumors of the ampulla of Vater. Cancer 2000; 76:1150-1154.
17. Zhu L, Kim K, Appert HE, et al: Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF alpha, CEA, and EMA. J Surg Oncol 1996; 61:100-105.
18. Park SH, Kim Y, Park YH, et al: Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg 2000; 24:54-59.
19. Achille A, Biasi MO, Zamboni G, et al: Cancers of the papilla of Vater: mutator phenotype is associated with good prognosis. Clin Cancer Res 1997; 3:1841-1847.
20. Zhao B, Kimura W, Futakawa N, et al: p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Am J Gastroenterol 1999; 94:2128-2134.